CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
Yoshihiro Kuwano(Saitama International Medical Center), Thomas F. Tedder(Duke Medical Center), Rei Watanabe(Osaka Ohtani University), Norihito Yazawa(The University of Tokyo), Manabu Fujimoto(Osaka Gakuin University), Hitoshi Okochi(Center for Global Health), K. Tamaki(The University of Tokyo), A. Kumanogoh(The University of Osaka), Nobuko Ishiura(The University of Tokyo), Charlene M. Prazma(Duke Medical Center)
Cited by 58
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
|The Journal of Experimental Medicine|2004|631
Sequential contribution of L- and P-selectin to leukocyte rolling in vivo.
|The Journal of Experimental Medicine|1995|585